52 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Dobutamine 2-20 mcg ... Isoproterenol 2-10 mcg ... Epinephrine 0-20 mcg ... Properties #Table #Pharmacology ... #Effect #Management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
REBEL Review 74: Push-Dose Epinephrine 

9 mL Saline + 1 mL Epi (100mcq/mL) = Epinephrine 10mcg/mL
Epinephrine 9 mL ... Saline + 1 mL Epi ... 10mcg/mL 0.5 ... #criticalcare #management ... #pharmacology
Vasopressors and Inotropes - Pharmacology Summary
Vasopressors
Phenylephrine (alpha-1)
 • Increases BP, SVR
 • Risk of reflex bradycardia
and Inotropes - Pharmacology ... mild alpha (5-10 mcg ... CO • a (>10 mcg ... Vasopressors #Inotropes #Pharmacology ... #Summary #management
Amiodarone Toxicity and Monitoring

Tremor Ataxia 
Ocular neuritis 
Corneal Microdeposits 
Bradycardia 
Pulmonary fibrosis 
Hepatotoxicity 
Blue-gray skin
Tremor Ataxia Ocular ... Adverse #Diagnosis #Management ... #Pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
100 cells/mm3 g/mL ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
A practical guide to starting levothyroxine therapy
Calculate full replacement dose: 1.6 mcg/kg/day
Young, otherwise healthy patient:
 •
replacement dose: 1.6 mcg ... Start at 25-50 mcg ... initiation #starting #management ... endocrinology #pharmacology
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
concentration: > 750ng/mL ... probably < 1500ng/mL ... malabsorption) if < 200ng/mL ... #rheumatology #pharmacology ... levels #lupus #management
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
if MIC<0.12 ug/ml ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology